Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Angina Pectoris, Variant”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,009 records · Page 56Linked to original sources
PubMed1983

Nitroglycerin and long-acting nitrates in clinical practice.

Nitrates are potent relaxers of vascular smooth muscle and act by dilating veins, arteries, and arterioles (especially at high doses). Their clinical effects have been considered to be dominantly related to peripheral actions: systemic venodilatation and a decrease in systemic vascular resistance, reducing the preload and afterload of the heart. Considerable experimental work confirms potent salutary effects on the coronary circulation. These drugs are readily absorbed across mucosal surfaces; they are available in multiple formulations, including sublingual, buccal, oral, and topical delivery systems. Nitrate administration should begin with low doses and increased to doses that are often higher than previously recommended until a specific clinical end point or limiting side effects occur. Organic nitrate esters are effective in the treatment of stable angina pectoris, unstable angina, coronary vasospastic syndromes, and in vasodilator therapy in severe congestive heart failure. The pathophysiology of these syndromes is reviewed with respect to the clinical actions of nitrates on the central and peripheral circulations. The side effects of nitrates include headache, dizziness, and nausea. Nitrate tolerance, a controversial subject, does not appear to be an important clinical problem. Using the guidelines presented in this review, nitrate therapy provides effective, inexpensive, well-tolerated therapy for many patients with cardiovascular disease.

Angina Pectoris↗
PubMed1983

Relation of therapeutic response to nifedipine to coronary anatomy and motion of S-T segment during unstable angina pectoris.

Of 77 patients hospitalized for unstable angina pectoris and failure of oral, dermal, or intravenous nitrates and/or beta blockade, 81 percent with negligible or single-vessel disease and 55 percent with two- or three-vessel disease showed response (p less than 0.05) to nifedipine therapy. Patients with either S-T elevation or no change during pain responded better (31 of 45) than those with any S-T depression (16 of 32; p less than 0.05). Patients with negligible or single-vessel disease had a higher prevalence of S-T elevation (13 of 16) than patients with two- or three-vessel disease (15 of 31; p = 0.004). S-T motion did not predict response in patients with two- or three-vessel disease, but did predict response in patients with negligible or single-vessel disease. On follow-up study at 9 +/- 8 (range one to 33) months, 39 of 42 who had shown response were free from pain. Three died from infarction without unstable angina. (range one to 33) months, 39 of 42 who had shown response were free from pain. Three died from infarction without unstable angina. Five who showed response had elective bypass surgery. The addition of nifedipine abolished or reduced pain episodes by more than 50 percent in 61 percent of patients with refractory unstable angina pectoris. Patients with negligible or single-vessel disease with S-T elevation benefit most. In patients with two- or three-vessel disease, the type of S-T motion did not predict response. Follow-up of all those with response indicated sustained amelioration by nifedipine therapy. Failure of nifedipine therapy should not be accepted until a dose of 120 mg per day has been achieved, or until intolerable side effects appear.

Adult↗
PubMed1991

Prinzmetal angina. Multifocal ischemia, recurrent AV block, and bradycardia with patent coronary arteries responsive to verapamil.

Coronary vasospasm may result in recurrent angina pectoris and cause acute myocardial infarction. The extent to which the "sudden death syndrome" occurs is unknown. The case described herein is unique in that the clinical features, including hypotension, AV block, and ventricular arrhythmias, were similar to those seen in myocardial infarction with a poor prognosis, yet infarction was not documented. In subsequent, long-term follow-up evaluation, chest pain has been recurrent, but despite close observation, no further major cardiac complications have been documented. Long-term use of verapamil has contributed to better control of clinical symptomatology.

Angina Pectoris, Variant↗
PubMed1984

Psychotherapeutic intervention in angina: I. A critical review.

This paper considers the literature on factors found to be associated with angina and pseudoangina, and attempts to delineate those psychosocial characteristics that might distinguish angina patients from either nonanginal CAD patients or from non-CAD normals. A cluster of characteristics emerges from both retrospective and prospective studies suggesting greater affective lability, "neuroticism," and perhaps physiologic reactivity than in either comparison group. The literature also suggests that learning and suggestion may play important roles in generating specific precipitants for anginal attacks. The literature on psychosocial intervention in anginal syndromes is almost entirely anecdotal, allowing few firm conclusions to be drawn, but suggesting the possible efficacy of certain behavioral, didactic, and supportive-psychodynamic interventions.

Angina Pectoris↗
PubMed1984

The electrocardiogram and coronary artery spasm.

This discussion does not attempt to explain why the ECG of patients during rest angina accompanied by coronary spasm sometimes demonstrates ST segment elevation, at other times less impressive changes and, on occasion, no important change. Regardless, the important point is that ECG changes during an episode of chest pain are not a necessary criterion for the diagnosis of angina pectoris either in patients presenting with rest or exertional chest pain syndromes.

Angina Pectoris, Variant↗
PubMed1984

What is the long-term prognosis of patients with coronary spasm and normal coronary arteries?

The clinical course of patients with pure coronary artery spasm is variable. Some patients have a chronic course characterized by recurrent angina at rest. Others develop spontaneous remission of symptoms. Most patients have a poor response to long-acting nitrate therapy and a good response to calcium antagonists. Despite the morbidity associated with this syndrome, cardiac mortality is low. When death occurs, it is usually sudden and probably secondary to an arrhythmia.

Angina Pectoris, Variant↗
PubMed1985

Abnormal heart rate control in vasospastic angina: effects of calcium antagonists.

We examined the effects of administration of calcium antagonists on the heart rate response to treadmill exercise in 11 patients with vasospastic angina and 8 healthy young volunteers. The exercise test was performed by walking on a treadmill at a constant speed and grade according to a scheme of pseudo-randomized sequence for 19 min. The dynamic property of heart rate response to exercise was evaluated by using a frequency analytic procedure. The exercise test was also studied in 21 age-matched normal controls without drug administration. Administration of calcium antagonists revealed no significant effects on heart rate and blood pressure at rest in young healthy subjects or in patients with vasospastic angina. Young volunteers showed the same normal properties of heart rate response to exercise before and after calcium antagonists. Vasospastic angina showed abnormal heart rate response to exercise and revealed characteristically different transfer function from that in normal controls. These characteristics were not affected by treatment with calcium antagonists except for a slight, uniform decrease of gain of the system over the whole frequency range. Accordingly, the present exercise test can feasibly be used in the diagnosis and management of vasospastic angina even when calcium antagonists are administered to the patients.

Administration, Oral↗
PubMed1985

Combined cardiac cinefluoroscopy, exercise testing and ambulatory ST-segment monitoring in the diagnosis of coronary artery disease; a report of 104 symptomatic patients.

To enhance diagnostic accuracy in coronary artery disease, cardiac cinefluoroscopy for the detection of coronary artery calcification was combined with exercise test and ambulatory ST-segment monitoring in 104 symptomatic patients before they underwent coronary angiography. In 44 patients with typical angina the combination of the three noninvasive tests and the exercise test alone both detected 92% of subjects with clinically important coronary artery disease. In 60 patients with atypical angina, the combination of the three noninvasive tests screened 77% of the subjects with clinically important coronary artery disease versus 43% after exercise test only (P less than 0.001). The exercise electrocardiogram was false negative in a substantial number of patients with atypical angina due to the presence of a good coronary reserve or to a daily circadian variation in the tone of the coronary arteries. Under these circumstances, cardiac cinefluoroscopy gave additional anatomic information to the physiological assessment of ischemia provided by the exercise test and ambulatory ST-segment monitoring. Our study suggests that the combination of cardiac cinefluoroscopy with other noninvasive tests may be particularly useful in screening atypically symptomatic populations.

Adult↗
PubMed1986

On the clinical value of thallium-201 washout analysis in the detection of multiple jeopardized myocardial regions.

In this study the relative importance of visual assessment and quantitative analysis myocardial stress perfusion scintigraphy in 72 patients with a 40% incidence of triple-vessel coronary disease was tested. The quantitative analysis of the uptake scintigram in combination with a washout rate study of thallium-201 was not superior to the visual analysis with regard to the overall detection of significant coronary disease (obstructions of at least 50%). The sensitivity of the quantitative analysis was 0.85 for the entire population and 0.90 for the triple-vessel disease group (specificity 0.90). Detection of jeopardized myocardial flow regions in patients with triple-vessel disease, however, resulted in a significantly better identification by quantitative analysis. Of the 87 jeopardized flow regions in the 29 patients with triple-vessel disease, 62 regions were detected by the quantitative analysis whereas 48 regions were noted by the visual evaluation. The post-test likelihood of this regional quantitative analysis with respect to the triple-vessel disease was 66%. The incidence of global ischemia as detected by washout abnormalities in cases with no or a maximum of one regional uptake defect was 7%.

Angina Pectoris↗